Huafu Zhou

12PUBLICATIONS
16CO-AUTHORS
Predictive and prognostic markersCross-sectional analysisGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Oct 30, 2026
PSMD12 is a novel potential biomarker for lung adenocarcinoma and associated with prognosis in lung adenocarcinoma patients.

|Jun 29, 2026
CCT7 Expression Affects the Prognosis of Lung Adenocarcinoma.

|Jun 13, 2025
High Circulating Platelet Count as a Risk Factor for Lung Squamous Cell Carcinoma: A Retrospective Study and Mendelian Randomization Analysis.

Guo-Sheng Li, Jun Liu, Yue Li

|Nov 23, 2024
The Impact of Economic Status on Cause-Specific Survival in Patients with Esophageal Adenocarcinoma in the United States: A Retrospective Analysis.

Xiu-Shun Xiang, Guo-Sheng Li, Jun Liu

|May 08, 2024
GTSE1: A potential prognostic and diagnostic biomarker in various tumors including lung adenocarcinoma.

Guanqiang Yan, Guosheng Li, Xiang Gao

|Oct 20, 2022
A Novel 5-Methylcytosine- and Immune-Related Prognostic Signature Is a Potential Marker of Idiopathic Pulmonary Fibrosis.

Tao Huang, Hua-Fu Zhou

Pageof 2

Frequent Collaborators

3 joint publications

Nuo Yang

2 joint publications

Gang Chen

2 joint publications

Yue Li

2 joint publications

Guo-Sheng Li